Trastuzumab

TRASTUZUMAB
Injection for Intravenous Use ● 150mg/vial ● 440mg/vial

HOW IT WORKS?

ANKEBIO TRASTUZUMAB is a monoclonal antibody specifically designed to inhibit the proliferation of human tumor cells that overexpress HER2.

WHO IS IT FOR?

ANKEBIO Trastuzumab is for patients with HER2*-overexpressing breast or gastric cancer *HER2, human epidermal growth factor receptor 2.

ANKEBIO Trastuzumab is indicated for the treatment of patients with:

Adjuvant Breast Cancer

Metastatic Breast Cancer

Metastatic Gastric Cancer